GlaxoSmithKline Bangladesh Limited announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was BDT 4,816.557 million compared to BDT 4,657.200 million a year ago. Operating income was BDT 1,183.204 million compared to BDT 1,033.262 million a year ago. Net loss was BDT 521.094 million compared to net income of BDT 548.829 million a year ago. Basic earnings per share from continuing operations was BDT 115.92 compared to BDT 67.88 a year ago. Basic loss per share was BDT 52.75 compared to basic earnings per share of BDT 55.56 a year ago.